Omega Therapeutics, Inc. Common Stock
OMGA
OMGA was delisted on the 24th of February, 2025.
4 hedge funds and large institutions have $2.5K invested in Omega Therapeutics, Inc. Common Stock in 2025 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 49 closing their positions.
85.39% less ownership
Funds ownership: 85.39% → 0% (-85%)
92% less funds holding
Funds holding: 53 → 4 (-49)
100% less capital invested
Capital invested by funds: $35.3M → $2.5K (-$35.3M)
100% less funds holding in top 10
Funds holding in top 10: 3 → 0 (-3)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 49
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FP
Flagship Pioneering
Cambridge,
Massachusetts
|
-$21.8M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.42M |
| 3 |
HP
Harbourvest Partners
Boston,
Massachusetts
|
-$2.62M |
| 4 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
-$1.38M |
| 5 |
SL
Siren LLC
Greenwich,
Connecticut
|
-$987K |
OMGA Hedge Fund Activity: Q1 2025 in Review
4 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in Omega Therapeutics, Inc. Common Stock (OMGA) for Q1 2025, worth a combined $2.5K — down 100% from $35.3M a quarter earlier.
Sellers outnumbered buyers: 49 funds closed out of OMGA and 0 opened new positions — a net loss of 49 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Flagship Pioneering, exiting entirely with an estimated $21.8M sold.
- 4 institutional investors held Omega Therapeutics, Inc. Common Stock (OMGA) as of Q1 2025, down from 53 in Q4 2024.
- Funds reported $2.5K of Omega Therapeutics, Inc. Common Stock stock for Q1 2025, down 100% quarter-over-quarter.
- 0 funds opened new Omega Therapeutics, Inc. Common Stock positions in Q1 2025 and 49 closed out, a net change of -49 holders.
- The largest Omega Therapeutics, Inc. Common Stock seller in Q1 2025 was Flagship Pioneering, an estimated $21.8M sold.
Based on aggregated 13F filings for Q1 2025.